Thermo Fisher Charts Impressive Q4 Results, Divests Pathology Business To PHC
Executive Summary
Thermo Fisher Scientific has surprised analysts with its Q4 and full year 2018 results. The US-based company reported an 8% increase in fourth-quarter revenues, year-over-year, led by steady growth across its four business segments.